Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED)…

Read The Full Article…Rexahn Pharmaceuticals To Initiate Zoraxel Phase IIb Trial For Treatment Of Erectile Dysfunction Read more »

Despite the very high rate of problems with sexual function among people with chronic kidney disease (CKD), little is known about the best treatment approaches in this group of patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN)…

Read The Full Article…Sexual Dysfunction In Kidney [...] Read more »

NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, announced results from a pre-clinical study showing that Vitaros®, the Company’s NexACT-based alprostadil product, significantly promoted healing of deep tissue wounds…

Read The Full Article…NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing Read more »

UroToday.com – Penile length and girth are reportedly decreased following radical prostatectomy for prostate cancer (CaP). However, it is not known whether patients experience similar shortcomings after HIFU or targeted cryoablation of the prostate (TCAP). A report in the online version of the Journal of Sexual Medicine by Dr. Li and colleagues form [...] Read more »

Even with the highly popular erectile dysfunction (ED) drugs like Viagra, Levitra and Cialis, penile implants still have a niche in the market, says Dr. J. Francois Eid, director of Advanced Urological Care, and Clinical Associate Professor of Urology at Weill/Cornell Medical College in New York City…

Read The Full Article…UrologicalCare.com: Size Matters: Dr. [...] Read more »

Despite a “bevy of birth control options” — ranging from pills, patches, rings and emergency contraception to longer-acting reversible methods and permanent sterilization options — “the rates of unplanned pregnancies remain high” in the U.S., Wall Street Journal columnist Melinda Beck writes…

Read The Full Article…WSJ Examines Factors Contributing To Unintended Pregnancies, Details Available Methods In [...] Read more »

As of mid-February, Bayer HealthCare faced more than 1,100 lawsuits in the U.S. from women alleging that the synthetic progestin in the birth control pills Yasmin and Yaz causes serious health programs, but various studies and experts are divided over whether the hormone poses higher risks than those in other birth control pills, the Los [...] Read more »

According to the Alerta 2010! Report on Conflicts, Human Rights and Peacebuilding, sexual violence was used as a weapon in most armed conflicts taking place in 2009. In addition to the report, the School for a Culture of Peace of Universitat Autonoma de Barcelona also published the Yearbook 2010 on Peace Processes…

Read The Full Article…The [...] Read more »

Reversing a 14-year decline, 23% more U.S. infants were born with syphilis in 2008 than in 2005, according to a Centers for Disease Control and Prevention report released Thursday, Reuters reports. The findings show that syphilis rates, which have increased among men who have sex with men, also are increasing in the heterosexual community, the researchers [...] Read more »

A new study from researchers at the Harvard School of Public Health (HSPH) and Children’s Hospital Boston has found that gay men, lesbians, bisexuals, and heterosexuals who have ever had a same-sex sex partner are one-and-a-half to two times as likely to experience violent events, especially in childhood, than the general population and have double [...] Read more »